AGP Picks
View all

Insurance Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Insurance Press Releases.

Press releases published on April 2, 2026

American Assets Trust, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Information
Exodus to Host Inaugural Shareholder Day, The Exodus Summit on May 1 in Omaha
KBR’s Mission Technology Solutions Supports NASA’s Artemis II Mission as Astronauts Embark on Historic Return to the Moon
Riot Announces First Quarter 2026 Production and Operations Updates
ULTRAGENYX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Ultragenyx Pharmaceutical Inc. Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action – RARE
QURE SHAREHOLDER ALERT: Hagens Berman Updates uniQure (QURE) Investigation Following Public FDA Rebukes and Allegations of “Distorted” Data
AOI Receives New Upsized Order for 800G Data Center Transceivers from Major Hyperscale Customer
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Safe Bulkers, Inc. Declares Quarterly Dividend on its 8.00% Series C Cumulative Redeemable Perpetual Preferred Shares; 8.00% Series D Cumulative Redeemable Perpetual Preferred Shares
Astera Labs Announces Conference Call to Review First Quarter 2026 Financial Results
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
Rush Enterprises, Inc. Conference Call Advisory for First Quarter 2026 Earnings Results
Grocery Outlet Holding Corp. Adds Two New Independent Directors
PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Athyrium Capital Management and Esperion Enter Into $50 Million Japan Royalty Financing to Support Strategic Acquisition of Corstasis Therapeutics
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ethos to Announce First Quarter 2026 Financial Results on May 6, 2026
Financial Institutions, Inc. Updates First Quarter 2026 Earnings Conference Call Details

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Insurance Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.